A study of thinking and memory after proton therapy for brain tumors
Official title: Neurocognitive Integrity After Proton Therapy for Brain Tumor
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This trial looks at how proton therapy affects thinking and memory in people with brain tumors.
Read our full plain-language summary
What the trial team says
Radiation therapy remains a cornerstone in the management of both benign and malignant intracranial tumors, either as monotherapy or combined with surgery and/or chemotherapy. Despite its therapeutic benefits, it is frequently associated with potential long-term adverse effects, with neurotoxicity posing a major challenge, especially in young patients affected by benign primary tumors.
Key facts
- Registry number
- NCT07836478
- Conditions studied
- Central Nervous System Tumour
Where it is running
This trial lists 1 site.
-
Italy
- European Institute of Oncology, Milan (Milan)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.